STI Incidence

DoxyPEP is an emerging evidence-based, low-cost tool for STI prevention. Here's what you need to know.

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Initial reports from the ongoing narrative collection Care Post Roe documenting poor-quality care, patient perspectives on telehealth medication abortion, adolescent preferences and experiences with pregnancy options counseling, and more.

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.

An analysis of the necessity for escort requirements in abortion care, tamoxifen to help with bleeding for implant users, depression and its possible correlation with unintended pregnancy, methods for remote gestational age assessment, and more.

Pregnancy intentions and outcomes in transgender, non-binary, and gender-expansive populations, PMS and PMDD treatment with OCPs, HPV vaccination in boys and men, increasing PreP awareness through more culturally competent materials, and more.